Zhang Xiaobin, Xie Jieqiong, Li Sha, Wang Xiangtao, Hou Xinpu
Department of Physical-Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing 100083, People's Republic of China.
J Drug Target. 2003 Feb;11(2):117-22. doi: 10.1080/1061186031000115150.
To improve transporting drugs across the Blood Brain Barrier (BBB) into the brain, RMP-7 was conjugated to the surface of liposomes containing Amphotericin B (AmB) for cerebral inflammation, because it can selectively bound to the B2 receptors on the capillary blood vessel. First, RMP-7 was conjugated to DSPE-PEG-NHS [1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-n-[poly (ethylenegly-col)]-hydroxy succinamide, PEG M 3400] under mild condition to obtain a predominantly 1:1 conjugate (DSPE-PEG-RMP-7), as evidenced by the Matrix-Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF-MS). The second, endothelium cell was cultured on the cell insert to form an in vitro BBB model and the stereoscan microscope, electric resistance and permeation of horse-radish peroxidase (HRP) across the endothelium cell monolayer were used as indicators to evaluate the integrality of the monolayer, and then the in vitro BBB model was used to determine the bioactivity of DSPE-PEG-RMP-7 "opening" BBB. The results demonstrated the in vitro BBB model was set up, RMP-7 and DSPE-PEG-RMP-7 could improve the transporting of HRP across the BBB. The third, the liposomes containing AmB (AmB-L-PEG) was prepared by modified Film-sonication method and DSPE-PEG-RMP-7 was used to modify the AmB-L-PEG to obtain AmB-L-PEG-RMP-7. The fourth, tissue distribution of AmB in the rats of three groups was determined: Group I, AmB-L-PEG; Group II, AmB-L-PEG+RMP-7 (the physical mixture of AmB-L-PEG and RMP-7); Group III, AmB-PEG-RMP-7. The drugs were transfused into the rats through the femoral vein. The concentration of AmB in the tissue was checked using High-Performance Liquid Chromatography (HPLC) method. The rank of AmB concentration in the brain were as follows: III>II>I. The AmB concentration in the liver, spleen, lung and kidney had no significant difference. The concentration of AmB in the brain of the group III was raised several times higher than that in the other two groups, because the DSPE-PEG-RMP-7 had been inserted in the surface of AmB-L-PEG. Both the RMP-7 and AmB-L-PEG could reach BBB at the same time. When RMP-7 selectively reacted with the B2 receptor, the BBB is "opened" and AmB was transported into the brain at the same time. While in group II, the RMP-7 could improve the AmB concentration in the brain a little, because the RMP-7 and liposomes could not reach BBB at the same time. The distribution of AmB in the tissues demonstrated that the RMP-7 and its derivative had selectivity to the brain.
为了提高药物穿过血脑屏障(BBB)进入大脑的能力,将RMP-7与含有两性霉素B(AmB)的脂质体表面偶联用于脑部炎症,因为它可以选择性地与毛细血管上的B2受体结合。首先,在温和条件下将RMP-7与DSPE-PEG-NHS[1,2-二油酰基-sn-甘油-3-磷酸乙醇胺-n-[聚(乙二醇)]-羟基琥珀酰胺,PEG M 3400]偶联,以获得主要为1:1的偶联物(DSPE-PEG-RMP-7),基质辅助激光解吸电离飞行时间质谱(MALDI-TOF-MS)证明了这一点。其次,将内皮细胞培养在细胞插入物上以形成体外血脑屏障模型,并使用立体扫描显微镜、电阻和辣根过氧化物酶(HRP)跨内皮细胞单层的渗透作为指标来评估单层的完整性,然后使用体外血脑屏障模型来确定DSPE-PEG-RMP-7“打开”血脑屏障的生物活性。结果表明建立了体外血脑屏障模型,RMP-7和DSPE-PEG-RMP-7可以改善HRP穿过血脑屏障的运输。第三,通过改良的薄膜超声法制备含有AmB的脂质体(AmB-L-PEG),并使用DSPE-PEG-RMP-7修饰AmB-L-PEG以获得AmB-L-PEG-RMP-7。第四,测定三组大鼠中AmB的组织分布:第一组,AmB-L-PEG;第二组,AmB-L-PEG+RMP-7(AmB-L-PEG和RMP-7的物理混合物);第三组,AmB-PEG-RMP-7。通过股静脉将药物输注到大鼠体内。使用高效液相色谱(HPLC)法检查组织中AmB的浓度。大脑中AmB浓度的排序如下:III>II>I。肝脏、脾脏、肺和肾脏中AmB的浓度没有显著差异。第三组大脑中AmB的浓度比其他两组高出几倍,因为DSPE-PEG-RMP-7已插入AmB-L-PEG的表面。RMP-7和AmB-L-PEG都可以同时到达血脑屏障。当RMP-7与B2受体选择性反应时,血脑屏障“打开”,同时AmB被转运到大脑中。而在第二组中,RMP-7可以稍微提高大脑中AmB的浓度,因为RMP-7和脂质体不能同时到达血脑屏障。AmB在组织中的分布表明RMP-7及其衍生物对大脑具有选择性。